» Articles » PMID: 22544864

Physical and Chemical Strategies for Therapeutic Delivery by Using Polymeric Nanoparticles

Overview
Journal Pharmacol Rev
Specialty Pharmacology
Date 2012 May 1
PMID 22544864
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

A significant challenge that most therapeutic agents face is their inability to be delivered effectively. Nanotechnology offers a solution to allow for safe, high-dose, specific delivery of pharmaceuticals to the target tissue. Nanoparticles composed of biodegradable polymers can be designed and engineered with various layers of complexity to achieve drug targeting that was unimaginable years ago by offering multiple mechanisms to encapsulate and strategically deliver drugs, proteins, nucleic acids, or vaccines while improving their therapeutic index. Targeting of nanoparticles to diseased tissue and cells assumes two strategies: physical and chemical targeting. Physical targeting is a strategy enabled by nanoparticle fabrication techniques. It includes using size, shape, charge, and stiffness among other parameters to influence tissue accumulation, adhesion, and cell uptake. New methods to measure size, shape, and polydispersity will enable this field to grow and more thorough comparisons to be made. Physical targeting can be more economically viable when certain fabrication techniques are used. Chemical targeting can employ molecular recognition units to decorate the surface of particles or molecular units responsive to diseased environments or remote stimuli. In this review, we describe sophisticated nanoparticles designed for tissue-specific chemical targeting that use conjugation chemistry to attach targeting moieties. Furthermore, we describe chemical targeting using stimuli responsive nanoparticles that can respond to changes in pH, heat, and light.

Citing Articles

Bio synthesis, comprehensive characterization, and multifaceted therapeutic applications of BSA-Resveratrol coated platinum nanoparticles.

Faisal S, Tariq M, Abdullah , Zafar S, Nisa Z, Ullah R Sci Rep. 2024; 14(1):7875.

PMID: 38570564 PMC: 10991511. DOI: 10.1038/s41598-024-57787-4.


NIR-II emissive donor-acceptor-donor fluorophores for dual fluorescence bioimaging and photothermal therapy applications.

Sparks N, Smith C, Stahl T, Amarasekara D, Hamadani C, Lambert E J Mater Chem C Mater. 2024; 12(12):4369-4383.

PMID: 38525159 PMC: 10955863. DOI: 10.1039/d3tc04747d.


Novel drug delivery strategies for antidepressant active ingredients from natural medicinal plants: the state of the art.

Yuan S, Ma T, Zhang Y, Wang N, Baloch Z, Ma K J Nanobiotechnology. 2023; 21(1):391.

PMID: 37884969 PMC: 10604811. DOI: 10.1186/s12951-023-02159-9.


Potential role of Chinese medicine nanoparticles to treat coronary artery disease.

Yang R, Gu Y, Qin J, Liu Q, Liu Q Heliyon. 2023; 9(9):e19766.

PMID: 37809499 PMC: 10559060. DOI: 10.1016/j.heliyon.2023.e19766.


Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics.

Kumari M, Acharya A, Krishnamurthy P Beilstein J Nanotechnol. 2023; 14:912-926.

PMID: 37701520 PMC: 10494237. DOI: 10.3762/bjnano.14.75.


References
1.
Kumari A, Yadav S, Yadav S . Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 2009; 75(1):1-18. DOI: 10.1016/j.colsurfb.2009.09.001. View

2.
Merkel T, Jones S, Herlihy K, Kersey F, Shields A, Napier M . Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles. Proc Natl Acad Sci U S A. 2011; 108(2):586-91. PMC: 3021010. DOI: 10.1073/pnas.1010013108. View

3.
Gratton S, Napier M, Ropp P, Tian S, DeSimone J . Microfabricated particles for engineered drug therapies: elucidation into the mechanisms of cellular internalization of PRINT particles. Pharm Res. 2008; 25(12):2845-52. PMC: 2593117. DOI: 10.1007/s11095-008-9654-8. View

4.
Wong C, Stylianopoulos T, Cui J, Martin J, Chauhan V, Jiang W . Multistage nanoparticle delivery system for deep penetration into tumor tissue. Proc Natl Acad Sci U S A. 2011; 108(6):2426-31. PMC: 3038705. DOI: 10.1073/pnas.1018382108. View

5.
van Duijnhoven S, Robillard M, Nicolay K, Grull H . Tumor targeting of MMP-2/9 activatable cell-penetrating imaging probes is caused by tumor-independent activation. J Nucl Med. 2011; 52(2):279-86. DOI: 10.2967/jnumed.110.082503. View